FindTrial
Sign In

Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: An innovative strategy including a computerised decision support system compared to a common strategy of professional audit and feedback

Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: An innovative strategy including a computerised decision support system compared to a common strategy of professional audit and feedback

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28902
Enrollment
400
Registered
2008-07-15
Start date
2009-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-eclampsia Pregnancy Gestational hypertension Implementation Guidelines Computerized decision support system Cost-effectiveness Implementatie, richtlijnen, pre-eclampsie, pre-existente hypertensie, zwangerschap, zwanherschapshypertensie

Interventions

Implementation strategy, BOS (beslissings ondersteunend systeem) versus audit and feedback.

Sponsors

ZonMw
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women who develop severe hypertension or preeclampsia

Exclusion criteria

Exclusion criteria: 1. Refusal to participate 2. Diagnosis of lethal fetal congenital abnormalities

Design outcomes

Primary

MeasureTime frame
The primary outcome measure for the evaluation of the effectiveness of both strategies is a combined rate of major maternal complications (maternal death, organ specific complications of hypertension, HELLP syndrome, placental abruption)—

Secondary

MeasureTime frame
- Guidelines' adherence rates - Fetal death rates - Caesarean delivery rates - Rates of neonatal mortality and morbidity - Experiences with the implementaion strategies. (participation etc)—

Contacts

Public ContactS.H.E. Luitjes

VU University Medical Center Department of Obstetrics and Gynaecology 8F-013 Postbus 1117

s.luitjes@vumc.nl+31 (0)6 20837607

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)